Misoprostol versus curettage in women with early pregnancy failure: impact on women's health-related quality of life. A randomized controlled trial
- PMID: 15831508
- DOI: 10.1093/humrep/dei019
Misoprostol versus curettage in women with early pregnancy failure: impact on women's health-related quality of life. A randomized controlled trial
Abstract
Background: We aimed to compare patients' health-related quality of life after a misoprostol strategy to a curettage in women with early pregnancy failure after failed expectant management.
Methods: A multicentre randomized clinical trial was performed in The Netherlands. In all, 154 women with early pregnancy failure confirmed at ultrasonography who had been managed expectantly unsuccessfully for > or =1 week were randomly assigned to undergo either treatment with misoprostol (n=79) or curettage (n=75). The main outcome measures were health-related quality of life and satisfaction with treatment.
Results: In the misoprostol strategy 47% of the women needed additional curettage, as compared to 4% after curettage. In both groups, health-related quality of life was impaired most severely 2 days after treatment. In the misoprostol group, health-related quality of life was more severely impaired; after 2 days this was due to more pain and after 2 and 6 weeks this was due to a worse general health perception. Health-related quality of life was temporarily significantly more impaired in women in whom misoprostol failed as compared to women in whom misoprostol treatment was successful. In both treatment groups, an equal percentage of women (58%) would choose the same treatment in the future. In women treated with misoprostol, however, this choice depended on the initial success of misoprostol: in cases where misoprostol had caused complete evacuation, 76% of the women would opt for the same treatment, whereas only 38% of women who needed curettage after unsuccessful misoprostol would do so (P<0.01).
Conclusion: Our study shows that, although both the misoprostol strategy and the curettage strategy resulted in complete evacuation in the end, women are willing to accept some disadvantages of misoprostol to avoid curettage. A treatment inconvenience using misoprostol is accepted as long as initial evacuation rate is high. This finding should be an integral part of counselling women when deciding upon management of early pregnancy failure.
Similar articles
-
Women's preferences for misoprostol in case of early pregnancy failure.Eur J Obstet Gynecol Reprod Biol. 2006 Feb 1;124(2):184-6. doi: 10.1016/j.ejogrb.2005.06.010. Epub 2005 Jul 18. Eur J Obstet Gynecol Reprod Biol. 2006. PMID: 16026923
-
Economic evaluation of misoprostol in the treatment of early pregnancy failure compared to curettage after an expectant management.Hum Reprod. 2005 Apr;20(4):1067-71. doi: 10.1093/humrep/deh709. Epub 2004 Dec 23. Hum Reprod. 2005. PMID: 15618248 Clinical Trial.
-
Randomized outpatient clinical trial of medical evacuation and surgical curettage in incomplete miscarriage.Eur J Contracept Reprod Health Care. 2001 Sep;6(3):141-4. Eur J Contracept Reprod Health Care. 2001. PMID: 11763977 Clinical Trial.
-
Expectant, medical, or surgical management of first-trimester miscarriage: a meta-analysis.Obstet Gynecol. 2005 May;105(5 Pt 1):1104-13. doi: 10.1097/01.AOG.0000158857.44046.a4. Obstet Gynecol. 2005. PMID: 15863551 Review.
-
Medical management of early pregnancy failure: how to treat and what to expect.Semin Reprod Med. 2008 Sep;26(5):401-10. doi: 10.1055/s-0028-1087106. Epub 2008 Sep 29. Semin Reprod Med. 2008. PMID: 18825608 Review.
Cited by
-
Medical treatments for incomplete miscarriage (less than 24 weeks).Cochrane Database Syst Rev. 2010 Jan 20;(1):CD007223. doi: 10.1002/14651858.CD007223.pub2. Cochrane Database Syst Rev. 2010. Update in: Cochrane Database Syst Rev. 2013 Mar 28;(3):CD007223. doi: 10.1002/14651858.CD007223.pub3. PMID: 20091626 Free PMC article. Updated.
-
A Systematic Review of Quality of Life Measures in Pregnant and Postpartum Mothers.Appl Res Qual Life. 2013 Jun 1;8(2):219-250. doi: 10.1007/s11482-012-9188-4. Appl Res Qual Life. 2013. PMID: 23734167 Free PMC article.
-
Women's physical health around live births and pregnancy losses: a longitudinal study.Eur J Public Health. 2025 Apr 1;35(2):335-341. doi: 10.1093/eurpub/ckaf013. Eur J Public Health. 2025. PMID: 39933033 Free PMC article.
-
Medical treatment for early fetal death (less than 24 weeks).Cochrane Database Syst Rev. 2019 Jun 17;6(6):CD002253. doi: 10.1002/14651858.CD002253.pub4. Cochrane Database Syst Rev. 2019. PMID: 31206170 Free PMC article.
-
Medical treatment for early fetal death (less than 24 weeks).Cochrane Database Syst Rev. 2006 Jul 19;2006(3):CD002253. doi: 10.1002/14651858.CD002253.pub3. Cochrane Database Syst Rev. 2006. Update in: Cochrane Database Syst Rev. 2019 Jun 17;6:CD002253. doi: 10.1002/14651858.CD002253.pub4. PMID: 16855990 Free PMC article. Updated.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical